Association between gut microbiota and peptic ulcer disease, particularly gastric ulcer and duodenal ulcer: a

Zhenhua Dong1, Kai Yu2, Yuchao Xin3

  • 1Department of Gastric and Colorectal Surgery, The First Hospital of Jilin University Changchun, Jilin, China.

Frontiers in Microbiology
|January 26, 2024
PubMed
Abstract

Insights

This study used Mendelian randomization to investigate the link between gut microbiota (GM) and peptic ulcer diseases (PUDs). Certain gut bacteria were found to causally influence gastric ulcers (GU) and duodenal ulcers (DU).

Area of Science:

  • Microbiome research
  • Gastroenterology
  • Genetics

Background:

  • Observational studies suggest a link between gut microbiota (GM) and peptic ulcer diseases (PUDs), including gastric ulcers (GU) and duodenal ulcers (DU).
  • The causal relationship between GM and PUDs remains unclear.

Purpose of the Study:

  • To investigate the potential causal relationship between gut microbiota and the risk of developing gastric ulcers (GU) and duodenal ulcers (DU).

Main Methods:

  • A two-sample Mendelian randomization (MR) study was conducted using data from the MiBioGend and FinnGen databases.
  • Single nucleotide polymorphisms (SNPs) were used as instrumental variables (IVs) at two significance thresholds (P < 5 × 10-8 and P < 1 × 10-5).
  • Inverse variance weighting (IVW) was employed to assess causal effects.

Main Results:

  • At P < 1 × 10-5, specific gut bacteria like Clostridiaceae1, Butyriccoccus, and Peptococcus were associated with increased GU risk, while LachnospiraceaeUCG004 and MollicutesRF9 showed protective effects.
  • For DU, several bacterial taxa including Lentisphaeria, Negativicutes, and Clostridiaceae1 were linked to increased risk, whereas Catenibacterium, Escherichia.Shigella, LachnospiraceaeUCG008, and Sutterella exhibited protective effects.
  • At the stricter threshold (P < 5 × 10-8), no significant causal influence of GM on GU or DU was detected.

Conclusions:

  • The two-sample MR analysis provides evidence for a causal relationship between specific gut microbiota compositions and the development of gastric ulcers (GU) and duodenal ulcers (DU).
  • Further research is warranted to elucidate the mechanisms underlying these gut microbiota-ulcer associations.

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
427
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
592
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
124
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
93